Neurotransmitter Related Immunocytochemistry of the Human Central Nervous System

  • J. Pearson
  • L. Brandeis
  • M. Goldstein
  • A. Claudio Cuello
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 18)


Immunocytochemical methods permit the precise anatomical study of neurotransmitter specific pathways in the human brain. It has been possible using antibodies to tyrosine hydroxylase (TH) to provide an atlas of human catecholaminergic (CA) neurons. A striking increase in complexity of CA neurons is seen in the human mesencephalon when compared with lower animals. Not only synthetic enzymes but also neurotransmitters themselves can be detected. Antibodies to the putative transmitter peptide substance P reveal its presence in axons and terminals. Areas of apparent interaction between systems can be studied and may give indications of distinct subdivisions within nuclei.

Alterations of specific neurons can be detected in human disease. It is possible to show increase in TH in the reduced numbers of sympathetic neurons in familial dysautonomia and to detect depletion of substance P containing primary sensory afferent terminals in this disease which is associated with decreased sensitivity to pain. Depletion of catechol-aminergic neurons is demonstrated in Parkinson’s disease.

Some neurotransmitters for which antibodies are available, notably serotonin, can be readily detected in animal tissue fixed by perfusion but, after death, rapidly diffuse away from their normal localization making their study virtually impossible in the human brain. Some antigens, such as TH, are present throughout the neuron in sufficient quantities to be immunocytochemically detectable; others, such as substance P, are detectable in axons and terminals but not (in the absence of colchicine treatment) in cell bodies.

Despite these difficulties immunocytochemistry has the potential of greatly increasing knowledge of human chemical neuroanatomy and pathology at the microscopic level of individual cells.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Pearson,J., Brandeis, L., Goldstein, M.: Appearance of tyrosine hydroxylase immunoreactivity in the human embryo. Devel. Neurosci. 3, 140–150 (1980).CrossRefGoogle Scholar
  2. [2]
    Pearson, J., Goldstein, M., Brandeis, L.: Tyrosine hydroxylase immunohistochemistry in human brain. Brain Res. 165, 333–337 (1979).CrossRefPubMedGoogle Scholar
  3. [3]
    Pearson, J., Goldstein, M., Markey, K., Brandeis, L.: Human brain stem catecholamine neuroanatomy as revealed by immunocytochemistry using antibodies to tyrosine hydroxylase. Neuroscience (in press).Google Scholar
  4. [4]
    Pearson, J., Brandeis, L., Goldstein, M.: Tyrosine hydroxylase immunoreactivity in familial dysautonomia. Science 206, 71–72 (1979).CrossRefPubMedGoogle Scholar
  5. [5]
    Pearson,J., Brandeis, L., Cuello, A. C.: Depletion of substance-P containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 295, 61–63 (1982).CrossRefPubMedGoogle Scholar
  6. [6]
    Pearson, J.: Neurotransmitter immunocytochemistry in the study of human development, anatomy and pathology. In: Progress in Neuropathology (Zimmerman, H.M., ed.). New York: Raven Press (in press).Google Scholar
  7. [7]
    Sternberger, L.A.: Immunocytochemistry. Chichester-New YorkBrisbane-Toronto: J. Wiley. 1979.Google Scholar
  8. [8]
    Parks, D. H., Goldstein, M.: Purification of tyrosine hydroxylase from pheochromocytoma tumor. Life Sci. 18, 55–60 (1976).CrossRefGoogle Scholar
  9. [9]
    Markey, K.A., Kondo, S., Shenkman, L., Goldstein, M.: Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Molec. Pharm. 17, 79–85 (1980).PubMedGoogle Scholar
  10. [10]
    Cuello, A. C., Gaffre, G., Milstein, C.: Detection of substance P in the central nervous system by a monoclonal antibody. Proc. Natl. Acad. Sci. (U.S.A.) 76, 3532–3536 (1979).CrossRefGoogle Scholar
  11. [11]
    Consolazione, A., Milstein, C., Wright, B., Cuello, A. C.: Immunocytochemical detection of serotonin with monoclonal antibodies. J. Histo-chem. Cytochem. 29, 1425–1430 (1981).CrossRefGoogle Scholar
  12. [12]
    Black, I.B., Green, S.C.: Post-mortem changes in brain catecholamine enzymes. Arch. Neurol. 32, 47–49 (1975).CrossRefPubMedGoogle Scholar
  13. [13]
    Cooper, P. E., Fernstrom, M. H., Leeman, S. E., Martin, J. B.: Distribution of somatostatin, substance P and neurotensin in the basal ganglia of the human. Soc. Neurosci. 6, 680 (1980).Google Scholar
  14. [14]
    Nobin, A., Björklund, A.: Topography of the monoamine neuron system in the human brain as revealed in fetuses. Acta. Physiol. Scand. 88, Suppl. 388, 1–40 (1973).Google Scholar
  15. [15]
    Dahlstrom, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurons in the mammalian nervous system. Acta. Physiol. Scand. 62, Suppl. 232, 1–55 (1964).Google Scholar
  16. [16]
    Felten, D.L., Laties, A. M., Carpenter, M.B.: Monoamine containing cell bodies in the squirrel monkey brain. Am. J. Anat. 139, 153–166 (1974).Google Scholar
  17. [17]
    Javoy-Agid, F., Taquet, H., Paloska, A., Cherif-Zahan, C., Ruberg M., Agid, Y.: Distribution of catecholamines in the ventral mesencephalon of the human brain with special reference to Parkinson’s disease. J. Neuro-chem. (in press).Google Scholar
  18. [18]
    Benno, R. H, Tucker, L. W., Joh, T. H., Reis, D.J.: Quantitative immunocytochemistry: I, Development of a computer assisted method using the PAP-technique. Brain Res. 246, 225–236 (1982).CrossRefPubMedGoogle Scholar
  19. [19]
    Steinbusch, H. W M.: Distribution of serotonin-immunoreactivity in the central nervous system of the rat: cell bodies and terminals. Neurosci. 6, 557–618 (1981).CrossRefGoogle Scholar
  20. [20]
    Jonakait, G. M., Tamir, H., Rapport, M. M., Gershon, M. D.: Detection of a soluble serotonin binding protein. J. Neurochem. 28, 277–284 (1977).CrossRefPubMedGoogle Scholar
  21. [21]
    Hertz, L., Tamir, H: Some properties of an astrocytic protein fraction that binds 5—HT. J. Neurochem. 37, 1331–1334 (1981).CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1983

Authors and Affiliations

  • J. Pearson
    • 1
  • L. Brandeis
    • 2
  • M. Goldstein
    • 2
  • A. Claudio Cuello
    • 2
  1. 1.Department of PathologyNew York University Medical Center School of MedicineNew YorkUSA
  2. 2.Department of PathologyNew York University Medical Center School of MedicineNew YorkUSA

Personalised recommendations